Spanish Red Biotech Pipeline

MSD

Pembrolizumab

Type: Biodrugs/ Drugs
Therapeutic area: Cancer
Indication: Pembrolizumab in Combination With Chemoradiotherapy (CRT) versus CRT Alone in Participants with Muscle Invasive Bladder Cancer
Phase: 3Phase III in Spain, 2Phase II, 1Phase I